- Home
- ALEC vs SNFCA Comparison
ALEC vs SNFCA Comparison
Compare ALEC & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALEC | SNFCA |
|---|---|---|
| Founded | 2013 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.8M | 229.2M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALEC | SNFCA |
|---|---|---|
| Price | $1.87 | $9.05 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.30 | N/A |
| AVG Volume (30 Days) | ★ 3.6M | 25.0K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 13.51 |
| EPS | N/A | ★ 0.60 |
| Revenue | $21,045,000.00 | ★ $344,587,538.00 |
| Revenue This Year | $43.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.15 |
| Revenue Growth | N/A | ★ 3.01 |
| 52 Week Low | $1.09 | $7.70 |
| 52 Week High | $3.40 | $10.23 |
Technical Indicators
Market Signals| Indicator | ALEC | SNFCA |
|---|---|---|
| Relative Strength Index (RSI) | 44.96 | 53.92 |
| Support Level | $1.43 | $8.53 |
| Resistance Level | $2.62 | $9.05 |
| Average True Range (ATR) | 0.21 | 0.19 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 14.00 | 61.42 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About SNFCA Security National Financial Corporation
Security National Financial Corp is a holding company providing insurance services. The company operates in three reportable business segments: Life insurance, Cemetery and Mortuary, and Mortgages. The life insurance segment sells and services selected lines of life insurance, annuity products, and accident and health insurance. The cemetery and mortuary segment engages in pre-need selling of funeral, cemetery, mortuary, and cremation services through its cemetery and mortuary locations. The mortgage segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and other real estate projects. It derives the majority of revenue from Life Insurance segment.